Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FUTIRST: Short vs Standard Antibiotic Treatment for Febrile UTI
NCT00809913Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2008
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ciprofloxacin in urinary tract infection (UTI) and acute pyelonephritis (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Clinical cure rate. Started Dec 2008; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
urinary tract infection (UTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT00809913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00809913.